KBC Group NV »

Precigen shares owned by KBC Group NV

Quarter-by-quarter ownership of Precigen (PGEN) shares owned by KBC Group NV from 13F filings

Historical chart of KBC Group NV investment in Precigen

Tip: Access up to 7 years of quarterly data

All positions including Precigen held by KBC Group NV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Precigen by KBC Group NV

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 346k 3.87

More positions owned by KBC Group NV

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Gilead Sciences (GILD)
Lam Research Corp Com New (LRCX)
Johnson & Johnson (JNJ)

View all positions for KBC Group NV

Top funds holding Precigen

Patient Capital Management
BlackRock
State Street Corporation
Vanguard Group
Vanguard Capital Management
Diametric Capital
Point72 Asset Management
Tang Capital Management
FMR
Geode Capital Management
Occam Crest Management
Driehaus Capital Management
Iridian Asset Management
Goldman Sachs Group
Citadel Advisors

View all funds holding Precigen